Yu Ting, Qian Dong, Zheng Yongping, Jiang Ya, Wu Ping, Lin Lin
From the Department of Gastroenterology (TY, YZ, YJ, PW, LL); Pancreas Center (DQ), the First Affiliated Hospital of Nanjing Medical University; Pancreas Institute (DQ), Nanjing Medical University; and Qinglongshan Mental Hospital (PW), Nanjing, China.
Medicine (Baltimore). 2016 May;95(19):e3667. doi: 10.1097/MD.0000000000003667.
The physiological mechanism of functional constipation (FC) includes defecatory disorders and delayed colon transit. About 18% to 68% constipated patients may have rectal hyposensitivity (RH). We performed this study to investigate the association between RH and functional defecatory disorder (FDD) as well as that between RH and delayed colon transit in FC patients.A total of 218 FC patients were enrolled. The constipation severity instrument (CSI) was used to assess constipation symptoms. High-resolution anorectal manometry (HR-ARM), defecography, balloon expulsion tests, and colon transit studies were performed for each patient. RH was defined as 1 or more sensory threshold pressures raised beyond the normal range based on HR-ARM. We investigated the association between RH and constipation symptoms, and the occurrence of FDD and delayed CTT. Ninety FDD patients completed the initial phase of biofeedback treatment (BFT). We investigated the association between RH and the effect of BFT.Totally 122 (56.0%) patients had RH. The total CSI (49.82 ± 1.09 vs 41.25 ± 1.55, P = 0.023) and obstructive defecation subscale scores (23.19 ± 0.69 vs 17.07 ± 0.90, P < 0.001) were significantly higher in RH than in non-RH patients. No significant difference was observed in slow transit symptoms (21.77 ± 0.72 vs 19.90 ± 0.85, P = 0.121) or abdominal pain (6.85 ± 2.61 vs 5.00 ± 1.04, P = 0.380). The frequency of prolonged CTT was not significantly different between RH and non-RH groups (54.1% vs 58.3%, P = 0.403). RH patients rated more occurrence of FDD (72.1% vs 53.1%, P = 0.014) and dysynergic defecation (79.8% vs 50.2%, P = 0.004) than non-RH patients, whereas no differences were seen for inadequate defecatory propulsion (59.2% vs 55.0%, P = 0.589). After BFT, the proportion of "no effect" was significantly higher in the RH group than in the non-RH group (22.4% vs 9.4%, P = 0.010).RH is associated with obstructive defecation symptoms and the occurrence of FDD. Further studies are needed to detect the mechanism of RH's effect on BFT and FC.
功能性便秘(FC)的生理机制包括排便障碍和结肠传输延迟。约18%至68%的便秘患者可能存在直肠感觉减退(RH)。我们开展本研究以调查FC患者中RH与功能性排便障碍(FDD)之间以及RH与结肠传输延迟之间的关联。
共纳入218例FC患者。使用便秘严重程度量表(CSI)评估便秘症状。对每位患者进行高分辨率肛肠测压(HR-ARM)、排粪造影、气囊排出试验和结肠传输研究。RH定义为基于HR-ARM,1个或更多感觉阈值压力超出正常范围。我们调查了RH与便秘症状、FDD的发生以及结肠传输时间延长(CTT)之间的关联。90例FDD患者完成了生物反馈治疗(BFT)的初始阶段。我们调查了RH与BFT效果之间的关联。
共有122例(56.0%)患者存在RH。RH患者的总CSI评分(49.82±1.09 vs 41.25±1.55,P = 0.023)和梗阻性排便子量表评分(23.19±0.69 vs 17.07±0.90,P < 0.001)显著高于非RH患者。在传输缓慢症状(21.77±0.72 vs 19.90±0.85,P = 0.121)或腹痛方面(6.85±2.61 vs 5.00±1.04,P = 0.380)未观察到显著差异。RH组和非RH组之间CTT延长的频率无显著差异(54.1% vs 58.3%,P = 0.403)。与非RH患者相比,RH患者中FDD的发生率更高(72.1% vs 53.1%,P = 0.014),排便协同失调的发生率更高(79.8% vs 50.2%,P = 0.004),而排便推进不足方面无差异(59.2% vs 55.0%,P = 0.589)。BFT后,RH组“无效”的比例显著高于非RH组(22.4% vs 9.4%,P = 0.010)。
RH与梗阻性排便症状及FDD的发生相关。需要进一步研究以探寻RH对BFT和FC产生影响的机制。